BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20161030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160705
DTEND;VALUE=DATE:20161101
DTSTAMP:20260829T141022
CREATED:20160705T124949Z
LAST-MODIFIED:20160706T133740Z
UID:16333-1467676800-1477958399@ces.b2sg.org
SUMMARY:Postdoc in Epigenetics/Cancer (Brussels\, Belgium)
DESCRIPTION:A postdoctoral position is immediately available in the Laboratory of Cancer Epigenetics headed by Prof. François Fuks (ULB – Université Libre de Bruxelles/Free University of Brussels\, Belgium). \nYou will be expected to conduct cancer research in epigenetics and epigenomics. Specifically\, you will investigate the mechanisms and functions of a novel epigenetic modification. The following recent publication has direct relevance to this project: Delatte B\, et al.\, Science. 2016; 351:282-5. Genetic\, biochemical and cell biological as well as genome-wide approaches (e.g. RNA-Seq\, ChIP-Seq\, Infinium Methylation) will be applied. The lab is running a Next Generation Sequencing (NGS) Illumina platform: EPICS (http://epics.ulb.be/) and is part of the new ULB-Cancer Research Center (U-CRC) directed by Prof. Fuks\, encompassing fundamental\, translational and clinical research and providing an excellent scientific environment to conduct high profile research.\nWe are looking for a highly motivated candidate with extensive experience in molecular and cell biology. Applicants should hold a PhD degree in Biochemistry/Molecular Biology or related disciplines (or have recently submitted their thesis with their defence scheduled) and have published (or about to publish) in a peer reviewed journal. Experience in epigenetics/epigenomics would be an asset. \nThe position is funded for 3 years. Screening of applications begins immediately and continues until an outstanding candidate is selected. Flexible starting date. \nInformal enquiries\, a CV\, a motivation letter and names of two referees should be send to: Valentina Albarani (valentina.albarani@ulb.ac.be) \nLab website: http://www.ulb.ac.be/medecine/fukslab\nLab NGS platform: http://epics.ulb.be/ \nSelected publications:\n– Delatte et al. Science 2016\n– Delatte et al. Science Rep. 2015\n– Boumahdi et al. Nature 2014\n– Deplus et al. Cell Rep. 2014\n– Delatte et al. EMBO J. 2014\n– Deplus et al. EMBO J. 2013\n– Volkmar et al. EMBO J. 2012\n– Dedeurwaerder et al. EMBO Mol Med. 2011\n– Fuks F. Nature. 2010\n– Epsztejn-Litman Nat Struct Mol Biol. 2008\n– Villa et al. Cancer Cell. 2007\n– Brenner & Fuks Dev Cell. 2007\n– Viré et al. Nature 2006\n– Brenner et al. EMBO J. 2005
URL:https://ces.b2sg.org/event/postdoc-in-epigeneticscancer-brussels-belgium/
LOCATION:ULB\,  Université libre de Bruxelles Campus Erasme\, Anderlecht\, 1070\, Belgium
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2016/07/ULB-Epigenetics-lab.jpg
ORGANIZER;CN="ULB-Lab%20Cancer%20Epigenetics":MAILTO:epics@ulb.ac.be
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160706
DTEND;VALUE=DATE:20161101
DTSTAMP:20260829T141022
CREATED:20160706T131829Z
LAST-MODIFIED:20160706T133508Z
UID:16337-1467763200-1477958399@ces.b2sg.org
SUMMARY:PhD in Epigenetics/Cancer (Brussels\, Belgium)
DESCRIPTION:A PhD position is available in the Laboratory of Cancer Epigenetics headed by Prof. François Fuks at the Université libre de Bruxelles (ULB)\, Brussels\, Belgium. \nYou will be expected to conduct cancer research in epigenetics and epigenomics. Specifically\, you will investigate the mechanisms and functions of a novel epigenetic modification. The following recent publication has direct relevance to this project: Delatte B\, et al.\, Science. 2016; 351:282-5. Genetic\, biochemical and cell biological as well as genome-wide approaches (e.g. RNA-Seq\, ChIP-Seq\, Infinium Methylation) will be applied. The lab is running a Next Generation Sequencing (NGS) Illumina platform: EPICS\, and is part of the new ULB-Cancer Research Center (U-CRC) directed by Prof. Fuks\, providing an excellent scientific environment to conduct high profile research encompassing fundamental\, translational and clinical research. \nCandidates with a good first degree (BSc or MSc) in Biology\, Genetics\, Biochemistry or a related life science subject are all invited to apply. Preferred qualifications include excellent grades\, research talent (as proven by the master thesis) and personal ambition. Candidates are expected to have good academic writing and presentation skills. Screening of applications begins immediately and continues until an outstanding candidate is selected. \nThe position is funded for 3 years\, in the first instance. Screening of applications begins immediately and continues until an outstanding candidate is selected. The starting date is September 30\, 2016 at the latest. \nInformal enquiries\, a CV (including grades and class ranking)\, a motivation letter and names of three referees should be send to: Valentina Albarani (valentina.albarani@ulb.ac.be) \nLab website: http://www.ulb.ac.be/medecine/fukslab \nLab NGS platform EPICS: http://epics.ulb.be/ \nUniversity website: https://www.ulb.ac.be/ulb/presentation/uk.html \nSelected publications:\n– Delatte et al. Science 2016\n– Boumahdi et al. Nature 2014\n– Deplus et al. Cell Rep. 2014\n– Delatte et al. EMBO J. 2014\n– Deplus et al. EMBO J. 2013\n– Volkmar et al. EMBO J. 2012\n– Dedeurwaerder et al. EMBO Mol Med. 2011\n– Fuks F. Nature 2010\n– Villa et al. Cancer Cell 2007\n– Viré et al. Nature 2006
URL:https://ces.b2sg.org/event/phd-in-epigeneticscancer-brussels-belgium/
LOCATION:ULB\,  Université libre de Bruxelles Campus Erasme\, Anderlecht\, 1070\, Belgium
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2016/07/ULB-Epigenetics-lab.jpg
ORGANIZER;CN="ULB-Lab%20Cancer%20Epigenetics":MAILTO:epics@ulb.ac.be
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20161005
DTEND;VALUE=DATE:20161009
DTSTAMP:20260829T141022
CREATED:20151229T231822Z
LAST-MODIFIED:20160625T073750Z
UID:12207-1475625600-1475971199@ces.b2sg.org
SUMMARY:Danube Scientific Conference on Epigenetics
DESCRIPTION:In the last couple of years the word epigenetics became used in several meanings. \nThis meeting will try to review the concepts of epigenetics\, the current state of the research in this field and the research methods of the field. Beside this we plan to be a meeting forum for the researchers and clinicians who are studying or planning to study topics in the field of epigenetics. \nWe plan to put forward those topics that deal mainly with the covalent modifications of the chromatin (DNA methylation and histone tail modifications) and their consequences especially those that define the transcriptional possibilities of a cell in a specific chromatin context. \nPlease join us at the meeting! We encourage everybody to submit an abstract. The results can be presented on posters or by talks\, most of which will be selected from the submitted abstracts.
URL:https://ces.b2sg.org/event/danube-scientific-conference-on-epigenetics/
LOCATION:Unnamed Venue\, Dudapest\, Hungary
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/Danube-Scientific-Conference-on-Epigenetics.png
END:VEVENT
END:VCALENDAR